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ELAV, a Drosophila neuron-specific protein, mediates the
generation of an alternatively spliced neural protein isoform
Sandhya P. Koushika, Michael J. Lisbin and Kalpana White
Background: Tissue-specific alternative pre-mRNA splicing is a widely used
mechanism for gene regulation and the generation of different protein isoforms,
but relatively little is known about the factors and mechanisms that mediate this
process. Tissue-specific RNA-binding proteins could mediate alternative pre-
mRNA splicing. In Drosophila melanogaster, the RNA-binding protein encoded
by the elav (embryonic lethal abnormal visual system) gene is a candidate for
such a role. The ELAV protein is expressed exclusively in neurons, and is
important for the formation and maintenance of the nervous system. 
Results: In this study, photoreceptor neurons genetically depleted of ELAV, and
elav-null central nervous system neurons, were analyzed immunocytochemically
for the expression of neural proteins. In both situations, the lack of ELAV
corresponded with a decrease in the immunohistochemical signal of the neural-
specific isoform of Neuroglian, which is generated by alternative splicing.
Furthermore, when ELAV was expressed ectopically in cells that normally
express only the non-neural isoform of Neuroglian, we observed the generation
of the neural isoform of Neuroglian. 
Conclusions: Drosophila ELAV promotes the generation of the neuron-specific
isoform of Neuroglian by the regulation of pre-mRNA splicing. The findings
reported in this paper demonstrate that ELAV is necessary, and the ectopic
expression of ELAV in imaginal disc cells is sufficient, to mediate neuron-specific
alternative splicing.
Background
In Drosophila melanogaster, the vital elav (embryonic lethal
abnormal visual system) gene is expressed pan-neurally in
all stages of development. The ELAV protein is present
exclusively in all immature and mature neurons [1]. Loss-
of-function alleles of elav are embryonic-lethal, and the
mutant embryos have an abnormally formed neuropil [2,3].
Hypomorphic mutations of elav produce aberrant eye
structures, defective electroretinograms and flight defects
[4,5]. The analysis of mutant clones in genetic mosaic flies
has also shown a post-embryonic role for ELAV in the
maintenance of photoreceptor cells, optic lobe and associ-
ated neuropil areas [5]. Thus, mutant phenotypes indicate
a role for elav in the formation and maintenance of the
nervous system.
The ELAV protein belongs to a large superfamily of
RNA-binding proteins that all have one or more repeats
of a well characterized RNA-binding domain (RBD; also
known as the RNA-recognition motif, RRM) of approxi-
mately 80 amino acids [6,7]. Members of this superfamily
are known to function in various aspects of RNA metabo-
lism. Examples include the Drosophila splicing factors Sxl
and Tra2, which are involved in sex-specific splicing,
polyA-binding proteins, and proteins associated with
snRNPs (small nuclear ribonucleoproteins) and hnRNPs
(heterogenous nuclear ribonucleoproteins) [7,8]. ELAV
has an alanine/glutamine-rich amino-terminal domain and
three RBDs; the first two RBDs are tandem and the third
RBD is separated from the first two by a hinge region [9].
ELAV-like proteins are conserved through evolution —
several genes encoding proteins with three RBDs, and
high homology to ELAV in these regions, have been
identified in Xenopus, mouse, zebra fish, human and rat
[10–12]. We and others have proposed that these proteins
modulate expression of subsets of genes by one or more
post-transcriptional mechanisms [1,12], but the absence
of identified downstream targets has prevented a full
understanding of their function.
The Drosophila neuroglian (nrg) gene encodes two isoforms
of the Neuroglian (Nrg) protein, which are generated by
alternative splicing; one of the isoforms, of 167 kDa, is
expressed ubiquitously (Nrg167), and the other, of
180 kDa, is expressed only in the nervous system (Nrg180)
[13]. In this paper, we show that elav regulates neural
expression of the nrg gene by promoting the formation of
the neural-specific isoform encoded by this gene. Further-
more, by expressing ELAV ectopically, we show that
neural Nrg180 can be generated in cells that normally
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express only the non-neural Nrg167 protein. In neurons,
therefore, ELAV is necessary, and its presence in imaginal
disc cells is sufficient, for the formation of the neural-
specific isoform of Nrg.
Results
A novel elav mutation reveals that expression of neural-
specific Nrg is ELAV-dependent
In order to identify the targets of elav, we analyzed the
expression of candidate genes in ELAV-deficient neurons.
We used a new elav transgene insert that encodes a wild-
type ELAV protein but has a novel phenotype due to its
expression pattern: Tf(2)elavedr (elav eye disc reduced) has reduced
ELAV expression in photoreceptors (Fig. 1c,d), but normal
expression in the central nervous system (CNS; data not
shown). Thus, flies of genotype elave5; Tf(2)elavedr (elave5 is
a null allele [14]) exhibited rough eyes and disorganized,
vacuolar retina (Fig. 1a,b), reminiscent of the mutant eyes
observed in elav mosaic flies [5].
We screened the expression of proteins in the ELAV-defi-
cient eye discs using immunocytochemistry. Proteins
screened included APPL [15], Chaoptin [16], Erect Wing
(EWG) [17], Fas II [18], Neurotactin [19], IrreC-rst [20],
Eyes absent [21], Glass [22] and neuron-specific Nrg180
[13]. We also used an anti-horseradish peroxidase antibody
[23], which recognizes several glycosylated membrane
proteins, and the monoclonal antibody 22C10 [24], which
recognizes photoreceptor membranes. Among these pro-
teins, the immunocytochemical signals for EWG (data not
shown) and neuron-specific Nrg180 appeared to be signifi-
cantly reduced in the mutant eye discs when compared
with wild-type eye discs (Fig. 2b,c). In the case of other
proteins, the immunocytochemical signal appeared unaf-
fected (data not shown), implying that protein synthesis
per se is normal in these ELAV-deficient neurons at this
stage. Furthermore, the ELAV-deficient eye disc did not
exhibit increased cell death, as assayed by acridine orange
staining [21] (data not shown), and the gross organization
of the photoreceptor clusters seemed regular (Fig. 1e,f).
These observations imply that the absence of ELAV has a
specific effect on the expression of EWG and Nrg180,
rather than a more general effect on protein synthesis. 
ELAV does not affect nrg transcription
As the two isoforms of Nrg are generated by differential
splicing of the 3′ exon [13], we investigated the expression
of nrg. A comparison of the cDNA sequences encoding
Nrg167 and Nrg180 indicated that the two isoforms are identi-
cal in the extracellular domain but differ in part of their
cytoplasmic domain [13]. We cloned the genomic region
corresponding to the alternatively spliced intron and
mapped the alternative exons, as described in Materials and
methods. As reported previously [13], a choice of 3′ splice
sites allows splicing either to the upstream Nrg167-specific
exon or to the downstream Nrg180-specific exon (Fig. 2a).
Nrg180 is expressed only in neurons; Nrg167 is more abun-
dant and more widely expressed, but whether it is
expressed in neurons is not known [13,25]. In order to
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Figure 1
Phenotypic characterization of flies carrying the elavedr transgene. 
(a,b) Horizontal histological sections through (a) wild-type and (b) elave5;
Tf(2)elavedr (ELAV-deficient) fly heads at the esophageal level.
Tf(2)elavedr is a transgene insert that provides elav vital function, but
results in a mutant eye phenotype. Note the abnormal retina (r) and the
fusion of the lamina (l) and medulla (m) in the ELAV-deficient head. Scale
bar in (b) represents 50 mm in (a,b). (c,d) ELAV immunoreactivity in (c)
wild-type and (d) ELAV-deficient eye disc; note the reduced staining in
the ELAV-deficient eye disc. Eye discs were immunoreacted with the
monoclonal antibody 9F [35], directed against ELAV. (e,f) Monoclonal
antibody 22C10 immunoreactivity in (e) wild-type and (f) ELAV-deficient
eye discs. 22C10 stains all photoreceptors. Note that there is no
apparent difference in the signal strength and pattern in the two discs.
There were no differences observed between mutant and wild-type
when examined by high magnification serial sectioning using confocal
microscopy (data not shown). Anterior is to the top and arrows point to
the morphogenetic furrow. Scale bar in (f) represents 50mm in (c–f).
investigate this question, we used two monoclonal anti-
bodies: 1B7 is directed against the extracellular domain of
Nrg, and can therefore detect both Nrg isoforms, whereas
the epitope recognized by BP-104 is cytoplasmic, and BP-
104 recognizes only Nrg180 in tissue extracts [13]. The
specificity of BP-104 for the protein generated by the
Nrg180 cDNA has been demonstrated in cell transfection
studies: BP-104 recognizes extracts of S2 cells transfected
with vectors expressing Nrg180 cDNA, but not those trans-
fected with Nrg167 cDNA; and BP-104 does not recognize
a mutated Nrg protein that lacks the cytoplasmic domain
[26]. As the only difference between the two isoforms is
the alternative exon [13], the epitope recognized by
BP-104 is indicative of the neuron-specific splice.
As previously reported by Hortsch et al. [13] for wild-type
eye discs, BP-104 recognized only the photoreceptors
(Fig. 2f), whereas 1B7 recognized both photoreceptors and
the epithelial cells of the ommatidia (Fig. 2g,h). To deter-
mine whether a reduction in Nrg180 in ELAV-deficient
photoreceptors was due to reduced transcription of nrg, we
tested for the expression of Nrg167 with 1B7. The overall
signal was similar to the wild-type discs (Fig. 2d,e), and
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Figure 2
(a) Genomic organization of the nrg alternatively spliced intron. The
top bar represents the genomic restriction map. Dark boxes represent
exons. A choice of 3′ splice site (ss) leads to a splice to either the
upstream Nrg167 or the downstream Nrg180 specific exon. Intron sizes
are estimated to be 1.5 kb for the 5′ ss to the Nrg167 exon 3′ ss and
3.2 kb for the 5′ ss to the Nrg180 exon’s 3′ ss. Abbreviations: E,
EcoRV; A, AlwNI; S, SalI; C, ClaI; B, BamHI; N, NdeI; R, EcoRI. 
(b–j) Characterization of Neuroglian immunoreactivity in wild-type and
ELAV-deficient mutants. In all panels, anterior is to the top; arrows in
(b–e) mark the morphogenetic furrow. (b,c) Wild-type (b) and ELAV-
deficient (c) eye discs immunoreacted to visualize Nrg180 with the
monoclonal antibody BP-104; the neural-specific isoform is highly
reduced in the ELAV-deficient disc. (d,e) Wild-type (d) and ELAV-
deficient (e) eye discs immunoreacted with 1B7, which recognizes
both Nrg167 and Nrg180, appear to yield similar signals, implying that
total Nrg levels are unaffected. The staining is all over the disc, which
appears faint due to the short film exposure time chosen to reveal the
differentiating ommatidia behind the morphogenetic furrow. (f–h)
High-magnification confocal images of a field of ommatidia. (f) Wild-
type disc immunoreacted with BP-104 shows Nrg180 confined to the
photoreceptors, whereas both wild-type (g) and ELAV-deficient (h)
discs immunoreacted with 1B7 show staining in both the photo-
receptors and the epithelial cells. White arrows point to photoreceptor
staining and black arrows point to the surrounding epithelial cells. The
relative staining of total Nrg in neural cells relative to non-neural cells
appears unchanged. These confocal sections were taken with discs
immunoprocessed at the same time and under identical laser/gain
settings of a Bio-Rad 600 confocal microscope. (i,j) Representative
photograph showing (i) ELAV-immunoreactivity and (j) Nrg180-
immunoreactivity in 12–15 h embryos from a cross in which 25 %
embryos are expected to be ELAV-null. Note that an ELAV-null embryo
(to the right in (i)) is also Nrg180-null (j). The other embryo has strong
CNS (central nervous system) and PNS (peripheral nervous system)
staining (+++) for ELAV and Nrg180. Scale bar in (d) and (i)
represents 50 mm for (b–e) and (i,j), respectively; bar in (f) represents
5 mm for (f–h).










the strength of the signal in the photoreceptor clusters
when compared with the surrounding epithelial cells was
similar in wild-type and ELAV-deficient discs (Fig. 2g,h).
These observations suggest that the absence of ELAV
does not affect the transcription of nrg, but rather that
ELAV promotes formation of the neuron-specific isoform
Nrg180, and that in its absence only the Nrg167 isoform is
generated.
ELAV affects the expression of Nrg180 in both peripheral
nervous system and central nervous system neurons
To further test the dependence of Nrg180 on the presence
of ELAV, ELAV-null clones in developing eye discs
were generated by somatic mobilization [27] of a P-
element carrying an elav+ transgene DmORF2 [28] (see
Materials and methods). Figure 3a shows a relatively
large ELAV-null somatic clone, in a disc immunoreacted
for ELAV (Fig. 3b) and Nrg180 (Fig. 3c). The merged
image shows that ELAV-null clones were indeed Nrg180
nulls (Fig. 3d), and that ELAV acts cell-autonomously —
the Nrg180 signal was absent only when the ELAV signal
was absent.
We further tested the dependence of Nrg180 synthesis on
ELAV in elav-null embryos. In the progeny of a cross
expected to yield 25 % ELAV-null male embryos, single
labeling with BP-104 indicated that 29 % were Nrg180-null
embryos; double-immunolabeling with anti-ELAV anti-
body and BP-104 indicated that 26 % were ELAV-null
and 23 % were Nrg180-null embryos (Table 1, Fig 2i,j).
The small fraction of ELAV-nulls that showed weak, but
above-background staining with BP-104 were likely to be
the result of experimental limitations (see Table 1
legend). Double-labeling with anti-ELAV antibody and
22C10 [24] resulted in virtually all embryos being 22C10-
immunoreactive, confirming the observation in eye discs
(Table 1). We therefore conclude that, similar to the situa-
tion in photoreceptors, the presence of Nrg180 in CNS
neurons correlates with the presence of ELAV.
Ectopic ELAV is sufficient to generate Nrg180 in tissues
that normally express Nrg167
If ELAV promotes formation of Nrg180, perhaps the pres-
ence of ELAV in a non-neural tissue that expresses nrg may
suffice to generate Nrg180. To test this idea, the GAL4/UAS
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Figure 3
Eye imaginal discs double-labeled for ELAV and Nrg180. (a) Eye disc of
the genotype elave5/ Y; Tf(3)elavDmORF2/ Ki pp (D2-3, ry+), showing a
large ELAV-null patch. Arrow in (a,b) points to the mutant patch. Scale
bar represents 50 mm. (b–d) High-magnification confocal image
through a part of elav-null mutant patch showing ELAV immuno-
reactivity in red (b) and Nrg180 immunoreactivity in green (c). The
merged image (d) shows that ELAV-null neurons are Nrg180-null.
Arrowheads in (a,c) point to the morphogenetic furrow and anterior is
to the top. Scale bar in (c) represents 10 mm in (b–d). 
(e–g) Ectopic expression of ELAV in wing imaginal discs double-
labeled for ELAV and Nrg180. High-magnification image from a wing
disc of the genotype c309/UAS-ELAV2e2 showing ELAV
immunoreactivity in red (e) and Nrg180 immunoreactivity in green (f),
and a merged image (g). Note that all Nrg180-positive cells are also
ELAV-positive, but that not all ELAV-positive cells are Nrg180-
immunoreactive. In these double-labeling experiments, ELAV and
Nrg180 were visualized using a rat polyclonal serum and BP-104,
respectively. Scale bar in (f) represents 5 mm in (e–g).
system was used to ectopically express ELAV [29]. In wild-
type wing discs, Nrg167 was expressed ubiquitously (Fig.
4a), whereas Nrg180 was not expressed in early wandering
third instar larvae [13] (Fig. 4b). We used a GAL4 enhancer
trap line, c309, to drive the UAS-elav transgene in patches of
wing-disc cells that do not normally express ELAV (Fig.
4c). In wing discs immunoreacted with BP-104, a signal
indicative of Nrg180 was visible where ELAV was expressed
at high levels (Fig. 4d), and  higher magnifications showed
that Nrg180 was on the cell surface (Fig. 4e). To test
whether the level of Nrg180 produced ectopically in wing
discs correlated with the concentration of ELAV, discs with
two doses of UAS-elav transgenes were analyzed (Fig. 4f).
Figure 4g shows that there was a clear enhancement in
Nrg180 signal, which corresponded to an increase in ELAV
concentration (Fig. 4f). High-magnification merged images
of wing imaginal disc cells carrying c309 and UAS-ELAV,
and double-immunolabeled for ELAV and Nrg180, showed
that all Nrg180-positive cells were ELAV-positive (Fig.
3e–g). As not all ELAV-positive cells were Nrg180-positive,
this splice must have a high threshold for ELAV in the wing
imaginal disc cells.
Discussion 
Taken together, the decrease or lack of Nrg180 when
ELAV is decreased or absent, and the generation of Nrg180
in non-neural cells when ELAV is ectopically expressed,
demonstrates that ELAV plays a key role in the generation
of the neuron-specific Nrg180 isoform. A simple hypothesis
explaining these findings is that ELAV is a trans-acting
tissue-specific protein that regulates splicing of nrg pre-
mRNA. The two nrg isoforms are generated by differential
choice of 3′ splice sites, where the 3′ splice site used for
Nrg167 mRNA is 5′ to the 3′ splice site used for Nrg180 (Fig.
2a) [13]. ELAV may therefore facilitate splicing of the
Nrg180-encoding mRNA by blocking the default splicing of
Nrg167-encoding mRNA, in a manner similar to that
observed for Sxl regulation of tra pre-mRNA splicing in
the sex-determination pathway [30]. ELAV may bind nrg
pre-mRNA directly, or the interaction with the pre-mRNA
may be indirect through other proteins involved in splic-
ing. In vertebrates, neuron-specific splicing factors have
been sought since the classic studies on alternative splicing
in the calcitonin/CGRP gene [31] and the c-src gene [32],
but specific cloned factors have not yet been reported.
At present we can not assess how many genes are directly
modulated by elav, or even whether the function of ELAV
is restricted to neuron-specific splicing events. It is clear,
however, that nrg is not the only elav-modulated gene, as
the CNS phenotype of loss-of-function alleles of nrg is
subtle [33] compared with the loss-of-function alleles of
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Table 1
ELAV and Nrg180 immunoreactivity in embryos.
Progeny of Antibody Immunoreactivity Signal strength (%) *
cross +++ ++ + +1/2 –
1. elave5wsn/+ ´ +/Y BP-104 Nrg180 10.4 31.9 16.6 11.8 29.1
n = 145
2. elave5wsn/+ ´ +/Y a-ELAV and ELAV 52.3 11.0 5.0 5.0 26.5 (15 %)†
n = 317 BP-104 Nrg180 48.8 13.5 4.7 9.4 23.3
3. Wild-type a-ELAV and ELAV 55.8 19.8 11.2 8.2 4.8 (46 %)†
n = 269  control BP-104 Nrg180 37.1 37.1 14.1 8.5 2.9
4. elave5wsn/+ ´ +/Y a-ELAV and ELAV 27.1 41.0 5.8 0.6 25.3
n = 324  control 22C10 22C10 52.0 38.0 8.0 1.5 0.3
5. Wild-type a-ELAV ELAV 57.8 21.7 13.4 4.1 2.7
n = 216  control
6. Wild-type BP-104 Nrg180 47.2 24.5 21.7 6.0 0.4
n = 216  control
*Signal strength was assigned on a scale of +++ to – using internal
comparison in a given batch of embryos. A score of +++ was given
when strong CNS and PNS staining were observed, ++ for less strong
staining in PNS and CNS. A score of + indicates weak CNS staining
and absence of, or weak, PNS staining and a score of +1/2 indicates
very low but discernible staining in CNS after careful examination at
higher magnification. †All ELAV-null embryos were independently
assessed for Nrg180 immunoreactivity, the numbers in parenthesis refer
to the percentage of ELAV-null embryos with discernible (+1/2) Nrg180
immunoreactivity. 12–15 h embryos were immunoreacted, mounted and
analyzed in a Zeiss inverted fluorescence microscope. 25 % of the
embryos from crosses 1, 2 and 4 are expected to be genetically elav-
null and hence have no ELAV immunoreactivity. Cross 4 demonstrates
that ELAV-null embryos are 22C10-positive. The other samples —
crosses 3, 5 and 6 — serve as additional controls for the uniformity of
immunostaining for various antibodies and embryo populations. In cross
2, from among the ELAV-null embryos, 84 % were also Nrg180-null;
however, 15 % showed weak but above-background staining with BP-
104. These are likely the result of experimental limitations — among the
control wild-type embryos, 4.8 % were ELAV-immunonegative, and
46 % of these were Nrg180-positive.
elav [2,3]. It is worth noting that ELAV may influence
axonal pathfinding, as nrg, also an essential gene, encodes
a cell-adhesion molecule [25,33]. Defects in axons that
form the longitudinal and transverse commisures in the
embryonic neuropil are apparent in elav-null mutant
embryos [3]. A decrease in EWG, a DNA-binding protein
that is expressed pan-neurally, was also observed in
ELAV-deficient eye discs; further studies are necessary to
test whether ELAV affects EWG expression directly or
indirectly. The phenotype of elav null mutants must result
from misregulation of the elav-modulated genes that are
expressed during embryogenesis. 
In recent years, a number of elav-like genes of the RRM
superfamily have been identified in Drosophila [14,34],
human [11,35], mouse [10], Xenopus [10] and zebra fish
[10]. Some elav-like proteins are found enriched in the
nucleus [11,34,35], and others in the cytoplasm [36]. Many
members of this subfamily show nervous system speci-
ficity [14,11,34,35]; however, ubiquitously distributed
ELAV-like protein has been described in Xenopus and
mouse [10]. In vitro studies with the mammalian brain-
specific proteins have led to the proposal that these pro-
teins regulate post-transcriptional processes by interacting
with AU-rich 3′ untranslated regions of mRNAs [12,35].
Based on findings reported here, we suggest that tissue-
specific alternative splicing is one of the functions of
ELAV-like proteins.
Conclusions
The results described here show that ELAV, a Drosophila
neuron-specific RNA-binding protein, is necessary for the
generation of the neural-specific Nrg180 isoform in
neurons. Furthermore, the ectopic expression of ELAV in
non-neural cells can promote the generation of this neural-
specific isoform. The identification of nrg as a downstream
target of elav regulation will facilitate mechanistic under-
standing of ELAV function, the identification of other
elav-regulated genes, and will help to define the pro-
cess(es) regulated by elav in neuronal differentiation and
maintenance.
Materials and methods
Fly stocks and genetic crosses
To study expression of other proteins in photoreceptors under elav
depleted conditions, discs from larvae of the genotype elave5; Tf(2)elavedr
were examined. Tf(2)elavedr (ELAV-deficient) is a transgene insertion on
the second chromosome which encodes a wild-type ELAV protein, under
the control of the elav promoter [34]. Other insertions of this transgene
provide both vital and photoreceptor functions of elav; however, this par-
ticular insert results in an eye phenotype (our unpublished results). elave5
is an interstitial deletion within the elav locus, and is elav-null [14].
To generate elav-null embryos, elave5 w sn/ + virgins were crossed to
wild-type CS males; 25 % of the progeny of this cross will be of the
genotype elave5 w sn/ Y and hence ELAV-null. 
To generate elav-null clones in the eye disc, we used the Tf(3)elavDmORF2
transgene, which encodes a wild-type ELAV protein, in a P-element
vector that provides full rescue of the elave5 null allele [27]. elav-null
clones in the eye discs were generated by inducing excisions of this
transgene using Ki pp (D2-3 ry+) [36]. Female virgins of the genotype
elave5; Tf(3)elavDmORF2/ TM3, Sb were crossed to y w/Y; Ki pp (D2-3
ry+)/ Ki pp (D2-3 ry+) males. All male progeny of this cross are of geno-
type elave5/Y; Tf(3)elavDmORF2/ Ki pp (D2-3 ry+) and can show D2-3-
mediated somatic loss clones for Tf(3)elavDmORF2 transposon. Eye discs
from male larvae were dissected and analyzed. 
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Figure 4
Wing imaginal discs from developing third instar larvae. (a,b) Wild-type
disc stained with (a) 1B7 and (b) BP-104. 1B7 stains homogeneously
throughout the disc, whereas BP-104 shows no staining; thus, only
Nrg167 is expressed at this stage. The signal in (a) is higher than that
seen in Fig. 2d,e because of increased film exposure time. (c,f) Wing
discs of genotype (c) c309/UAS-ELAV2e2 and (f) c309/UAS-ELAV2e2;
UAS-ELAV3e1 immunoreacted with anti-ELAV 9F antibody. Note the
increased expression of ELAV in (f) compared with (c); the arrow points
to one such group of cells. (d,e) c309/UAS-ELAV2e2 and (g)
c309/UAS-ELAV2e2; UAS-ELAV3e1 wing discs stained with BP-104 to
visualize Nrg180. Ectopic expression of ELAV results in ectopic
expression of neural-specific Nrg180 in non-neural cells. Arrows indicate
a representative cell group that shows an increase in concentration of
Nrg180 with an increase in ELAV concentration. (e) A high-magnification
confocal image of a section — box shown in (d) — through the Nrg180-
expressing disc, showing the protein at the cell membrane. Scale bar in
(g) represents 50 mm  in (a–d, f,g); bar in (e) represents 5 mm.
For ectopic ELAV expression, we used UAS-ELAV2e2 and UAS-ELAV3e1
transgene inserts on chromosome 2 and 3, which express elav cDNA
under UAS control. c309 is a GAL4 enhancer trap line with the trans-
gene insertion on the second chromosome. Ectopic expression of ELAV
was achieved by mating UAS-ELAV2e2 or UAS-ELAV2e2; UAS-ELAV3e1
virgin females to c309 males. All progeny from this cross express ELAV
ectopically.
Histology
3–5 day old male flies were fixed overnight at 4 oC in FAAG and subse-
quently dehydrated through an alcohol series and xylene. The heads were
embedded in paraffin and 8 mm sections were cut and stained with Maey-
er’s hematoxylin and Pollack trichome. The detailed procedure is
described in [5].
Immunohistochemistry
Imaginal discs were fixed in 4 % paraformaldehyde (pH 7.2) for 40 min.
and washed several times in PBS containing 0.1 % BSA and 0.3 %
Triton-X100, antibody incubations were carried out overnight at 4 °C.
Immunocytochemistry for each antibody with wild-type and mutant discs
was performed at the same time and, in all cases, at least 20 discs from
different animals for each genotype were examined. 12–15 h staged
embryos were collected, dechorionated with 50 % bleach and fixed for
30 min in 1:1 4 % paraformaldehye (pH 7.2):heptane. The embryos were
devitillenized using 1:1 heptane:methanol and subsequently stored at
–20 °C in methanol. Immunostaining was carried out after passing the
embryos through a methanol series and finally PBT. All subsequent steps
were identical to immunoproccessing of disc tissue. 
Photography was carried out using a Zeiss Axiophot fluorescence micro-
scope and Tmax-400 film. Negatives and prints were processed using
identical exposures, developing conditions and magnification.
Antibodies
Monoclonal antibody 9F [37], directed against ELAV was used at 1:20,
rat polyclonal directed against ELAV [1] was used at 1:200; the mono-
clonal antibodies BP-104 and 1B7 [13,25] were diluted 1:1, and 22C10
was used at 1:25 dilution. Secondary antibodies were bought from
Jackson Immunoresearch Laboratories and used at a dilution of 1:50 or
1:100. In double-labeling experiments using embryos, ELAV was visual-
ized using an affinity-purified rat polyclonal serum and a-rat-LRSC
(minimum cross-reactive to mouse immunoglobulins); BP-104 or 22C10
were detected using a coupled system, with a secondary antibody conju-
gated to biotin (minimum cross-reactive to rat immunoglobulins) and
streptavidin-FITC, to improve the strength of the signal. In double-labeling
experiments with imaginal discs, Nrg180 was visualized using BP-104 and
a secondary antibody conjugated to FITC, minimum cross reactive to rat
immunoglobulins. All secondary antibodies were tested for the absence
of cross-reactivity. 
Confocal microscopy
Optical sections were taken using the Bio-Rad MRC-600 confocal micro-
scope equipped with a krypton/argon laser. When separate samples
were to be compared, they were viewed at the same time using identical
laser/gain settings and printing conditions. Double-labeled imaginal discs
were checked for bleed-through of signal and under the conditions used
was observed to be absent. Images were processed using COMOS
program and were printed on a Sony color printer. 
Cloning of genomic sequences
To clone the genomic region spanning the alternatively spliced exons
from cosmids containing the nrg locus [38], oligonucleotides named
OF1, SR2 and LR2 were synthesized using published sequences [13] to
serve as probes for the common exon, the Nrg167-specific exon and
Nrg180-specific exon, respectively.
OF1 sequence: 5′ CGCTGGTCGCCAATCCGTGAGTTCAGCGAAC 3′
SR2sequence:5′GCGCTGCTTACTAATTAAATCAAAGTCCTTTGCGTC 3′
LR2 sequence: 5′ TGATGCGCCGCAGCGGAATTGTTCAGTGGCTG 3′
The end-labeled oligonucleotides were used to screen, in Southern blots,
a series of cosmids spanning the 7D to 7F region (Genome Mapping
project, Institute of Molecular Biology and Biotechnology, Heraklion,
Crete, Greece [38]). The probes hybridized to three overlapping cosmids,
168F4, 48C2, 1B2. The region spanning the intron was PCR amplified
with Pwo polymerase (Boehreinger Mannheim) and cloned into
pBluescipt (Stratagene) after ligating to Xba linkers. The cloned intron
fragment was restriction mapped and the identity of the genomic region
was further confirmed by partial sequencing of the exons and comparing
with the published sequence [13] in this region. 
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